NCT00938184View on ClinicalTrials.gov

Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 14, 2009

Primary Completion Date

September 2, 2009

Study Completion Date

September 2, 2009

Conditions
Depressive Disorder
Interventions
DRUG

Paroxetine 12.5 milligrams tablet

Single dose of paroxetine 12.5 milligrams controlled release tablet will be administered orally.

DRUG

Paroxetine 25 milligrams tablet

Single dose of paroxetine 25 milligrams controlled release tablet will be administered orally.

DRUG

Paroxetine 50 milligrams tablet

Single dose of paroxetine 50 milligrams controlled release tablet (as two tablets of 25 milligrams) will be administered orally.

Trial Locations (1)

108-8642

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00938184 - Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects | Biotech Hunter | Biotech Hunter